Join us for a comprehensive webinar exploring data privacy and governance considerations when using real-world data (RWD) in commercial pharmaceutical settings.

This session will delve into critical questions such as:

Untangling the Privacy Knot: How does genetic data differ from de-identified lab results or claims data in terms of privacy? We'll shed light on these distinctions to empower you to navigate the legal and ethical landscape of RWD use with confidence.

Safeguarding Patient Data: Learn about the essential safeguards and red flags to consider when granting access to genetic testing data by pharmaceutical companies or third-party vendors. Discover the criteria for selecting trustworthy partners who prioritize patient privacy.

De-identification Demystified: We'll explore effective techniques to ensure robust de-identification of patient data when accessed by third parties. Gain valuable insights into maintaining patient privacy throughout the RWD utilization process.

Register now and gain the knowledge to navigate the complexities of data privacy and governance when leveraging RWD for commercial pharmaceutical endeavors.

If you are interested in attending please fill out the below form and we will send you a Zoom invitation.

Prognos Webinar on April 5, 2024